Impact of the initiation of flash glucose monitoring (FGM) on glycemic control parameters in adult patients with type 2 diabetes mellitus.

INTRODUCTION

The effective implementation of the FGM contributes to achieving glycemic control, reducing hypoglycemic and hyperglycemic decompensations as well as enhancing patient self-management and improving their perception of quality of life. The aim of our study was to evaluate the glycemic control in type 2 diabetes patients after having implemented FGM in clinical practice.

MATERIAL AND

METHODS

Current patients with type 2 diabetes treated in our unit were monitored (FGM). A Structured Therapeutic Education Program was carried out and glycemic control variables were compared at the start and after 3 months of treatment.

RESULTS

A total of 36 patients were included (mean age of 67.8±12.4 years, 36.11% female, diabetes duration 21.5±2.12 years and a previous median glycated hemoglobine of 7.55%). Comparing the baseline data and the measures at 3 months, it was found a decrease in both glucose management indicator (GMI) (0.15% [0.40;0.30], P 0,537) and the coefficient of variation (CV) (1,42±4,66%, P 0,07), as well as an increase in time in range (TIR) (3,44±14.72%, P 0,169). Furthermore, a decrease in time in hyperglycemia >250mg/dl was observed (2,00% [-6,50;0,00] P 0,001).

CONCLUSION

FGM has led to a favorable advance in the management and glycemic control in patients with type 2 diabetes.